Literature DB >> 12040550

Barbiturate coma for intracranial hypertension: clinical observations.

Etienne Dereeper1, Jacques Berré, Arlette Vandesteene, Florence Lefranc, Jean-Louis Vincent.   

Abstract

PURPOSE: To determine the neurologic outcome of patients with intracranial hypertension treated with barbiturate-induced coma.
MATERIALS AND METHODS: The records of 49 patients who were admitted to a 31-bed medicosurgical intensive care unit over a 5-year period in whom a barbiturate coma was induced to control intracranial hypertension were analyzed retrospectively. Analysis included assessment of the response to barbiturate coma and evaluation of the long-term neurologic outcome according to the Glasgow Outcome Scale (GOS).
RESULTS: Intracranial hypertension was caused by head trauma in 28 patients and subarachnoid hemorrhage in 21 patients. Eight of the head trauma patients and 5 of the patients with subarachnoid hemorrhage survived their hospital stay. The survivors were younger than the nonsurvivors, and had a good neurologic status after 1 year (except for 2 patients who died 1 and 3 months after discharge, respectively). There was no significant difference in the Glasgow Coma Score (GCS) on admission between the survivors and the nonsurvivors. The long-term outcome at 1 year was markedly better in the patients who had experienced a subarachnoid hemorrhage than in the trauma patients. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12040550     DOI: 10.1053/jcrc.2002.33032

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  2 in total

1.  The effect of barbiturate coma therapy for the patients with severe intracranial hypertension: a 10-year experience.

Authors:  Young-Il Kim; Seung-Won Park; Taek-Kyun Nam; Yong-Sook Park; Byung-Kook Min; Sung-Nam Hwang
Journal:  J Korean Neurosurg Soc       Date:  2008-09-30

2.  Early use of barbiturates is associated with increased mortality in traumatic brain injury patients from a propensity score-based analysis of a prospective cohort.

Authors:  Maxime Léger; Denis Frasca; Antoine Roquilly; Philippe Seguin; Raphaël Cinotti; Claire Dahyot-Fizelier; Karim Asehnoune; Florent Le Borgne; Thomas Gaillard; Yohann Foucher; Sigismond Lasocki
Journal:  PLoS One       Date:  2022-05-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.